[PharmaEssentia] Announcement of Key Resolutions from the 2026 Annual General Meeting
PharmaEssentia held its 2026 Annual General Meeting on May 28, approving the 2025 profit distribution, financial statements, and a capital increase via retained earnings.
📋 Article Processing Timeline
- 📰 Published: May 28, 2026 at 09:00
- 🔍 Collected: May 29, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: May 31, 2026 at 18:35 (58h 35m after Collected)
1. Date of the Annual General Meeting: 2026/05/28
2. Key Resolution 1, Profit Distribution or Loss Offsetting: Approved the 2025 profit distribution proposal.
3. Key Resolution 2, Articles of Incorporation Amendment: None.
4. Key Resolution 3, Business Report and Financial Statements: Approved the 2025 business report and financial statements.
5. Key Resolution 4, Election of Directors and Supervisors: None.
6. Key Resolution 5, Other Matters: Approved the proposal for a capital increase by capitalization of earnings (issuance of new shares).
7. Other Matters to be Noted: None.
2. Key Resolution 1, Profit Distribution or Loss Offsetting: Approved the 2025 profit distribution proposal.
3. Key Resolution 2, Articles of Incorporation Amendment: None.
4. Key Resolution 3, Business Report and Financial Statements: Approved the 2025 business report and financial statements.
5. Key Resolution 4, Election of Directors and Supervisors: None.
6. Key Resolution 5, Other Matters: Approved the proposal for a capital increase by capitalization of earnings (issuance of new shares).
7. Other Matters to be Noted: None.
FAQ
What is PharmaEssentia?
A Taiwan-based biopharmaceutical company specializing in the development of treatments for rare diseases.